Literature DB >> 31920452

Spontaneous malignant glaucoma: Case report and review of the literature.

Julio González-Martín-Moro1,2, Lourdes Iglesias-Ussel3, Rosario Cobo-Soriano1,2, Yolanda Fernández-Miguel1, Inés Contreras4,5.   

Abstract

Malignant glaucoma usually occurs after anterior segment surgery (typically after glaucoma surgery). The aim of this article is to report a case of spontaneous malignant glaucoma (SpMG), which required phacovitrectomy for resolution and to review the cases of SpMG reported in modern literature. Only nine cases were identified. SpMG has no gender predilection and age at onset seems to be lower (mean age 47 years) than in secondary malignant glaucoma (SeMG). Nearly in half of the reported patients (4 out of 9) the condition had a bilateral presentation. The risk factors that have been identified for SeMG (nanophthalmos, shallow anterior chamber, iris plateau, zonular laxity) are underrepresented in SpMG.
© 2018 The Authors.

Entities:  

Keywords:  Acute glaucoma; Aqueous misdirection; Ciliary block glaucoma; Malignant glaucoma; Ocular hypertension

Year:  2018        PMID: 31920452      PMCID: PMC6950959          DOI: 10.1016/j.sjopt.2018.11.005

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


Introduction

Malignant glaucoma was first described by von Graefe in 1869. It is a rare condition characterized by an acute intraocular pressure (IOP) rise with a very shallow anterior chamber in the presence of a patent peripheral iridotomy. Malignant glaucoma usually occurs after anterior segment surgery. Most cases of secondary malignant glaucoma (SeMG) are reported after filtration surgery. The mechanism leading to malignant glaucoma is poorly understood. The most accepted theory suggests that in an anatomically predisposed eye, the anterior rotation of the ciliary body induces misdirection of aqueous flow into or behind the vitreous body, increasing vitreous volume, resulting in anterior displacement of the iris–lens diaphragm, axial and peripheral anterior chamber flattening, and secondary angle closure.[2], [3] Only a few cases of spontaneous malignant glaucoma (SpMG) have been reported in the literature.[4], [5], [6], [7], [8], [9], [10], [11], [12] The aim of this article is to describe a case of SpMG, to review if the risk factors associated with SeMG are present in patients with SpMG and if the therapeutic approaches that are useful in SeMG are also valid in SpMG.

Case report

A 57 year-old male patient was seen in our hospital after a ten-day-history of intermittent pain on his left eye (LE). During the previous day, the patient had also noticed severe visual loss and the pain had increased and become constant. He had a past medical history of high blood pressure, hiatal hernia, chronic renal failure, hyperuricemia and renal litiasis and was on treatment with valsartan and allopurinol. Visual acuity was hand movements in his LE. Anterior chamber examination revealed the presence of intense corneal edema and a very shallow anterior chamber (Fig. 1) and Goldman tonometry was 55 mmHg in his LE. A shallow anterior chamber was also present in his right eye (RE) without significant cataract. Fundus examination, although hindered by corneal edema, revealed no abnormalities. The diagnosis of acute angle closure glaucoma was made and the patient was treated with two cycles of intravenous 20% manitol, topical 0.5% timolol, and topical brimonidine. After four hours IOP remained higher than 50 mmHg. Oral acetazolamide and topical dexamethasone were added and a laser peripheral Nd-YAG iridotomy was attempted. As laser treatment was unsuccessful, a surgical iridectomy was performed two hours later.
Fig. 1

Anterior segment of the left eye at presentation, with a very shallow anterior chamber and severe corneal edema.

Anterior segment of the left eye at presentation, with a very shallow anterior chamber and severe corneal edema. On the following day, despite the presence of a patent iridectomy, IOP remained higher than 45 mmHg. Posterior segment ultrasonography showed no choroidal or vitreous abnormalities. However, anterior segment ultrasound biomicroscopy (UBM) found an anterior displacement of the iris-lens diaphragm (Fig. 2). The initial diagnosis was switched to malignant glaucoma. Ocular biometry found a normal axial length (RE 23.40 mm; LE 23.51 mm) with shallow anterior chambers (RE: 2.02; LE 1.69 mm). A central phacovitrectomy (with the implantation of a 21.5 diopter intraocular lens) normalized IOP. Postsurgical UBM showed a repositioning of the iris-lens diaphragm (Fig. 2). After two months corneal edema resolved in the LE and sixteen months later uneventful phacoemulsification was performed in the RE. In the last examination, two years after presentation, VA was 0.9, IOP was 20 mmHg without treatment and a severe visual field defect (DM −15.56 dB) was present in the patient`s LE.
Fig. 2

Anterior segment ultrasound biomicroscopy (UBM) showed anterior displacement of the iris-lens diaphragm. After combined phaco-vitrectomy UBM showed repositioning of the iris-lens diaphragm.

Anterior segment ultrasound biomicroscopy (UBM) showed anterior displacement of the iris-lens diaphragm. After combined phaco-vitrectomy UBM showed repositioning of the iris-lens diaphragm.

Discussion

Malignant glaucoma is among the most challenging ophthalmologic problems.(1) Some cases of SeMG have been reported after miotic therapy, non-glaucomatous anterior segment surgery or anterior segment laser procedures.[1], [2], [3], [13]. However SeMG typically occurs after glaucoma filtration surgery in eyes with angle closure. The incidence after glaucoma surgery has been reported to be as high as 2%. In contrast, SpMG is a very rare condition, and only a few cases have been reported (Table 1).[4], [5], [6], [7], [8], [9], [10], [11], [12] It is interesting to note that a significant proportion of these spontaneous cases had a bilateral presentation.
Table 1

Summary of the published cases of spontaneous malignant glaucoma.

Author, yearClinical informationGenderAge at onsetPseudoexfoliationHyperopiaTreatment
Schwartz, 1975UnilateralM85NoNoIntracapsular cataract surgery and vitreous aspiration
Fanous, 1983UnilateralF45NoNoMedical: cycloplegia
Manku, 1985BilateralM37NoNoMedical (pilocarpine, acetazolamide, manitol)
McClellan, 1988UnilateralDown syndromeKeratoconus, acute hydropsF47NoNoIntracapsular cataract surgery and vitreous aspiration
Gonzalez, 1992HyperuricemiaBilateralM55NoNoTrabeculectomy and iridectomySclerotomy
Amini, 2005BilateralM37NoNoLE:1.Trabeculectomy and extracapsular cataract extraction2.PPV and HyaloidectomyRE: Atropine
Park, 2012Aphakia, hypotony, traumatism UnilateralM38NoNoMedical: cycloplegia, timolol, manitol
Premsenthil, 2012Previous iridotomyF56NoNoPhacoemulsification and PPV
Jarade, 2014BilateralF24NoNoTrabeculectomy and PPV
Present caseUnilateralHyperuricemiaM57NoYesPhacoemulsification and PPV

M male; F female; PPV pars plana vitrectomy.

Summary of the published cases of spontaneous malignant glaucoma. M male; F female; PPV pars plana vitrectomy. SeMG seems to be more prevalent in women: the location of the lens is more anterior than in men, resulting in a shallower anterior chamber and a narrower space between the lens equator and the ciliary body. Indeed, in Zarnowski’s series nine out of ten patients were women. However SpMG seems to have a similar incidence in both genders (Table 1). Mean age of onset of the reported SpMG cases (47 years) seems to be lower than in SeMG (63 years in Zarnowski’s series). SeMG is rarely bilateral; however nearly half of the reported cases of SpMG (4/9) had a bilateral presentation. Other reported risk factors are a previous history of primary angle closure, pseudoexfoliation syndrome (lax zonular fibers might facilitate the fluid passage), hyperopia, and a previous history of malignant glaucoma in the contralateral eye.[1], [15] All of them seem to be less frequent in patients with SpMG. Although some cases can be controlled with medical treatment, malignant glaucoma usually requires surgical procedures. The aim of treatment is to disrupt misdirection and to restore normal aqueous flow. The classical intervention, described by Chandler in the sixties, was the aspiration of vitreous with an 18 gauge needle through an incision in the pars plana. Since then, capsulotomy, laser iridotomy and hyaloidotomy, vitrectomy and transscleral cyclophotocoagulation have been reported to be useful in the treatment of this condition.[2], [3]. These techniques are usually applied in a step-wise approach. Vitrectomy, if necessary, should be total with surgical disruption of the anterior hyaloid and zonule to break the primary mechanism of aqueous misdirection. It is equally useful in malignant glaucoma secondary to filtration and non filtration surgery and seems to be the most effective intervention. The nine cases identified of SpMG span over four decades. The table reflects the important changes that have taken place in the approach to malignant glaucoma. Our patient represents the third published case in which vitrectomy was used to treat SpMG.[4], [12] In conclusion, SpMG has a younger age of onset than SeMG, it is more frequently bilateral and pars plana vitrectomy seems to be the best procedure to achieve resolution when medical treatment is unsuccessful.

Conflict of interest

None.
  14 in total

1.  Spontaneous onset of ciliary block glaucoma in acute hydrops in Down's syndrome.

Authors:  K A McClellan; F A Billson
Journal:  Aust N Z J Ophthalmol       Date:  1988-11

2.  Outcomes of different management options for malignant glaucoma: a retrospective study.

Authors:  Veroniek Debrouwere; Peter Stalmans; Joachim Van Calster; Werner Spileers; Thierry Zeyen; Ingeborg Stalmans
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-20       Impact factor: 3.117

3.  Transscleral cyclodiode laser photocoagulation in the treatment of aqueous misdirection syndrome.

Authors:  Thomas H Stumpf; Michael Austin; Philip A Bloom; Andrew McNaught; James E Morgan
Journal:  Ophthalmology       Date:  2008-07-31       Impact factor: 12.079

4.  Treatment outcomes in malignant glaucoma.

Authors:  Paaraj Dave; Sirisha Senthil; Harsha L Rao; Chandra S Garudadri
Journal:  Ophthalmology       Date:  2013-01-31       Impact factor: 12.079

5.  Spontaneous malignant glaucoma in a longstanding hypotonous eye.

Authors:  Sang Woo Park; Jae Kyoun Ahn; Hwan Heo
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2012-10-01

6.  Ciliary block glaucoma: malignant glaucoma in the absence of a history of surgery and of miotic therapy.

Authors:  S Fanous; G Brouillette
Journal:  Can J Ophthalmol       Date:  1983-10       Impact factor: 1.882

7.  Malignant glaucoma: a review of the modern literature.

Authors:  H Shahid; J F Salmon
Journal:  J Ophthalmol       Date:  2012-03-27       Impact factor: 1.909

8.  Spontaneous simultaneous bilateral malignant glaucoma of a patient with no antecedent history of medical or surgical eye diseases.

Authors:  Elias F Jarade; Ali Dirani; Elyse Jabbour; Joelle Antoun; Karim F Tomey
Journal:  Clin Ophthalmol       Date:  2014-05-27

9.  Spontaneous malignant glaucoma in a patient with patent peripheral iridotomy.

Authors:  Mallika Premsenthil; Mohamad Aziz Salowi; Chong Min Siew; Intan ak Gudom; Tan Kah
Journal:  BMC Ophthalmol       Date:  2012-12-14       Impact factor: 2.209

10.  Simultaneous bilateral "malignant glaucoma" attack in a patient with no antecedent eye surgery or miotics.

Authors:  F Gonzalez; M Sanchez-Salorio; P Pacheco
Journal:  Eur J Ophthalmol       Date:  1992 Apr-Jun       Impact factor: 1.922

View more
  2 in total

1.  Management of a Bilateral Post-Uveitic Complex Glaucoma with Pupillary Block, Rupture of the Anterior Lens Capsule, and Malignant Glaucoma following Laser Peripheral Iridotomies: Case Report and Literature Review.

Authors:  Khaled El Matri; Dhouha Gouider; Rim Limaiem; Ahmed Chebil; Meher Henchiri; Yousra Falfoul; Leila El Matri
Journal:  J Curr Ophthalmol       Date:  2022-07-26

2.  Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis.

Authors:  Leif Hynnekleiv; Alexander Stanley Thrane; Jørgen Krohn
Journal:  BMJ Case Rep       Date:  2020-10-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.